Insider · CIK 0001916048
Eric Warren
Files at ESPR (Esperion Therapeutics, Inc.), MLYS (Mineralys Therapeutics, Inc.). First filing Oct 18, 2024, latest Sep 22, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MLYS: Mineralys Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 12Weak | Mineralys Therapeutics, Inc. | $209k 7,438 shares | -16% | +26% from low-40% from high | |
| 23Weak | Esperion Therapeutics, Inc. | $106 108 shares | -0% | - | |
| 30Weak | Esperion Therapeutics, Inc. | $3,618 2,433 shares | -1% | - | |
| 23Weak | Esperion Therapeutics, Inc. | $446 239 shares | -0% | - | |
| 23Weak | Esperion Therapeutics, Inc. | $278 123 shares | -0% | - | |
| 30Weak | Esperion Therapeutics, Inc. | $5,426 2,234 shares | -1% | - | |
| 15Weak | ESPRsell Esperion Therapeutics, Inc. | $427 197 shares | -0% | - | |
| 15Weak | ESPRsell Esperion Therapeutics, Inc. | $227 107 shares | -0% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | MLYS Mineralys Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +7,438 | $13.24 | $98k | 45,838 | 20 d ago |
| Sep 21, 2026 | MLYS Mineralys Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -7,438 | $28.12 | $209k | 38,400 | 20 d ago |
| Sep 21, 2026 | MLYS Mineralys Therapeutics, Inc. | MOption exercise Stock Optionderivative10b5-1 | -7,438 | $0.00 | $0 | 230,563 | 20 d ago |
| Apr 17, 2025 | ESPR Esperion Therapeutics, Inc. | SOpen-market sale Common Stock | -108 | $0.98 | $106 | 370,218 | Apr 21, 2025 |
| Mar 18, 2025 | ESPR Esperion Therapeutics, Inc. | SOpen-market sale Common Stock | -2,433 | $1.49 | $3,618 | 370,326 | Mar 19, 2025 |
| Mar 14, 2025 | ESPR Esperion Therapeutics, Inc. | AGrant or award Common Stock | +213,000 | $0.00 | $0 | 372,759 | Mar 17, 2025 |
| Mar 14, 2025 | ESPR Esperion Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +191,000 | $0.00 | $0 | 191,000 | Mar 17, 2025 |
| Feb 19, 2025 | ESPR Esperion Therapeutics, Inc. | SOpen-market sale Common Stock | -239 | $1.87 | $446 | 159,759 | Feb 20, 2025 |
| Jan 17, 2025 | ESPR Esperion Therapeutics, Inc. | SOpen-market sale Common Stock | -123 | $2.26 | $278 | 159,998 | Jan 21, 2025 |
| Dec 17, 2024 | ESPR Esperion Therapeutics, Inc. | SOpen-market sale Common Stock | -2,234 | $2.43 | $5,426 | 160,121 | Dec 18, 2024 |
| Nov 19, 2024 | ESPR Esperion Therapeutics, Inc. | SOpen-market sale Common Stock | -197 | $2.17 | $427 | 162,355 | Nov 20, 2024 |
| Oct 17, 2024 | ESPR Esperion Therapeutics, Inc. | SOpen-market sale Common Stock | -107 | $2.12 | $227 | 162,552 | Oct 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.